Perwez Alam

Dr. Perwez Alam

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Acta Biomaterialia
Verified
Journal Article
Closed access
RWRenae Waters
Renae Waters
PAPerwez alam
Perwez alam
SPSettimio Pacelli
Settimio Pacelli
ACAparna R. Chakravarti
Aparna R. Chakravarti
RARafeeq P.H. Ahmed
Rafeeq P.H. Ahmed
Arghya PaulArghya Paul
Arghya Paul

25 September 2017 in Journal of Molecular Medicine
Verified
Journal Article
Closed access
PDF file
MAMohammed Arif
Mohammed Arif
RPRaghav Pandey
Raghav Pandey
PAPerwez alam
Perwez alam
SJShujia Jiang
Shujia Jiang
Sakthivel SadayappanSakthivel Sadayappan
Sakthivel Sadayappan
RARafeeq P. H. Ahmed
Rafeeq P. H. Ahmed

6 August 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
PAPerwez alam
Perwez alam
BHBereket Haile
Bereket Haile
MAMohammed Arif
Mohammed Arif
RPRaghav Pandey
Raghav Pandey
MRMiso Rokvic
Miso Rokvic
OKOnur Kanisicak
Onur Kanisicak
Background: Myocardial infarction results in a large‐scale cardiomyocyte loss and heart failure due to subsequent pathological remodeling. Whereas zebrafish and neonatal mice have evident cardiomyocyte expansion following injury, adult mammalian cardiomyocytes are principally nonproliferative. Despite historical presumptions of stem cell–mediated cardiac regeneration, numerous recent studies using advanced lineage‐tracing methods demonstrated that the only source of cardiomyocyte renewal originates from the extant myocardium; thus, the augmented proliferation of preexisting adult cardiomyocytes remains a leading therapeutic approach toward cardiac regeneration. In the present study we investigate the significance of suppressing cell cycle inhibitors Rb1 and Meis2 to promote adult cardiomyocyte reentry to the cell cycle. Methods and Results: In vitro experiments with small interfering RNA –mediated simultaneous knockdown of Rb1 and Meis2 in both adult rat cardiomyocytes, isolated from 12‐week‐old Fischer rats, and human induced pluripotent stem cell–derived cardiomyocytes showed a significant increase in cell number, a decrease in cell size, and an increase in mononucleated cardiomyocytes. In vivo, a hydrogel‐based delivery method for small interfering RNA –mediated silencing of Rb1 and Meis2 is utilized following myocardial infarction. Immunofluorescent imaging analysis revealed a significant increase in proliferation markers 5‐ethynyl‐2′‐deoxyuridine, PH 3, KI 67, and Aurora B in adult cardiomyocytes as well as improved cell survivability with the additional benefit of enhanced peri‐infarct angiogenesis. Together, this intervention resulted in a reduced infarct size and improved cardiac function post–myocardial infarction. Conclusions: Silencing of senescence‐inducing pathways in adult cardiomyocytes via inhibition of Rb1 and Meis2 results in marked cardiomyocyte proliferation and increased protection of cardiac function in the setting of ischemic injury.

27 May 2016 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
CKChetna Kharbanda
Chetna Kharbanda
MAMohammad Sarwar Alam
Mohammad Sarwar Alam
HHHinna Hamid
Hinna Hamid
KJKalim Javed
Kalim Javed
SBSameena Bano
Sameena Bano
MPM. A. Qadar Pasha
M. A. Qadar Pasha

1 August 2020 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
PAPerwez alam
Perwez alam
GAGarima Agarwal
Garima Agarwal
RKRahul Kumar
Rahul Kumar
AMAastha Mishra
Aastha Mishra
NSNeeru Saini
Neeru Saini
MPM. A. Qadar Pasha
M. A. Qadar Pasha
Hypobaric hypoxia poses stress to sojourners traveling to high-altitude. A cascade of physiological changes occurs to cope with or adapt to hypobaric hypoxia. However, an insufficient physiological response to the hypoxic condition resulting from imbalanced vascular homeostasis pathways results in high-altitude pulmonary edema (HAPE). The present study aims to identify the implication of miRNAs associating with HAPE and adaptation. We analyzed the expression of 1,113 miRNAs in HAPE-patients (HAPE-p), HAPE-free controls (HAPE-f), and highland natives (HLs). Based on miRNA profiling and in silico analyses, miR-124-3p emerged relevantly. We observed a significant overexpression of miR-124-3p in HAPE-p. In silico analyses revealed a direct interaction of miR-124-3p with vascular homeostasis and hypoxia-associated genes NOS3 (endothelial nitric oxide synthase), Apelin, and ETS1 (V-Ets avian erythroblastosis virus E2 oncogene homolog 1). Moreover, the transcript and biolevel expression of these genes were significantly decreased in HAPE-p when compared with HAPE-f or HLs. Our in vitro analysis in human umbilical vein endothelial cells demonstrated a significant knockdown of these genes both at transcript and protein levels following miR-124-3p overexpression. Conclusively, our results showed that miR-124-3p might play a plausible role in HAPE pathophysiology by inhibiting the expression of NOS3, Apelin, and ETS1.

1 July 2007 in Clinica Chimica Acta
Verified
Journal Article
Closed access
EAEhtesham Arif
Ehtesham Arif
AVArpana Vibhuti
Arpana Vibhuti
PAPerwez alam
Perwez alam
DDDesh Deepak
Desh Deepak
BSBhawani Singh
Bhawani Singh
MPM.A. Qadar Pasha
M.A. Qadar Pasha